ClinicalTrials.Veeva

Menu

Oleocanthal Rich Olive Oil Acute Effects on Hyperglycemia and Platelet Activation in T2DM

H

Harokopio University

Status

Unknown

Conditions

Diabetes Mellitus, Adult-Onset
Inflammation
Postprandial Hyperglycemia
Oxidative Stress
Lipidemia
Platelet Dysfunction

Treatments

Other: White bread
Other: Butter
Other: EVOO with 500 mg/kg oleocanthal
Other: Ibuprofen
Other: EVOO with 250 mg/kg oleocanthal
Other: Refined olive oil

Study type

Interventional

Funder types

Other

Identifiers

NCT04419948
79549/16-05-2019

Details and patient eligibility

About

This is a pilot acute dietary intervention study with a randomized cross-over design aiming to investigate whether acute supplementation of extra virgin olive oil (EVOO) rich in oleocanthal could attenuate postprandial hyperglycemia and activation of platelets in T2DM patients. For this reason, non-insulin dependent diabetic patients (10-15) will be randomly assigned to consume in five different days white bread (50 g CHO) with butter, butter with ibuprofen, refined olive oil and olive oil with oleocanthal (250 mg/Kg 500 mg/Kg). Blood samples will be collected pre- and post-intervention up to 4 hours in order to determine platelet aggregation, postprnadial glycemia, lipemia, inflammation and oxidative stress.

Taking into account the strong anti-inflammatory and anti-platelet properties of oleocanthal, this study will assess whether oleocanthal-rich olive oils could exert similar effects under real in vivo conditions in T2DM patients. It will also assess whether these effects are achieved through improvement of postprandial glycemia and lipemia.

Enrollment

15 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • adult patients diagnosed with T2DM
  • stable weight the last two months
  • smokers or not
  • no restriction regarding the menopause

Exclusion criteria

  • insulin therapy
  • antiplatelet, anti-coagulant, anti-inflammatory and anti-depressant medication
  • chronic inflammatory disease
  • autoimmune diseases
  • cancer
  • uncontrolled thyroid disease.
  • supplement consumption the last two months

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

15 participants in 5 patient groups

Control
Experimental group
Description:
100g white bread plus 40ml butter
Treatment:
Other: White bread
Other: Butter
Positive control
Experimental group
Description:
100g white bread plus 40ml butter and 400mg ibuprofen
Treatment:
Other: Ibuprofen
Other: White bread
Other: Butter
Refined olive oil
Experimental group
Description:
100g white bread plus 40ml refined olive oil
Treatment:
Other: White bread
Other: Refined olive oil
EVOO with moderate concentration of oleocanthal
Experimental group
Description:
100g white bread plus 40ml EVOO containing 250 mg/kg oleocanthal
Treatment:
Other: EVOO with 250 mg/kg oleocanthal
Other: White bread
EVOO with high concentration of oleocanthal
Experimental group
Description:
100g white bread plus 40ml EVOO containing 500 mg/kg oleocanthal
Treatment:
Other: White bread
Other: EVOO with 500 mg/kg oleocanthal

Trial contacts and locations

1

Loading...

Central trial contact

Maria Efthymia Katsa, MSc; Tzortzis Nomikos, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems